BioMarin Pharmaceuticals BMRN Balance Sheet Statement
| FY'25 | FY'24 | FY'23 | FY'22 | ||
|---|---|---|---|---|---|
| $1.31B+39.1% | $942.84M+24.9% | $755.13M+4.2% | $724.53M+23.4% | ||
| $248.93M+27.7% | $194.86M-38.9% | $318.68M-43.8% | $567.01M+32.9% | ||
| $908.21M+37.5% | $660.54M+4.2% | $633.7M+37.4% | $461.32M+23.5% | ||
| $1.3B+5.4% | $1.23B+11.3% | $1.11B+23.8% | $894.08M+15.1% | ||
| $3.95B+22.3% | $3.23B+9.3% | $2.96B+7.4% | $2.75B+21.0% | ||
| $952.51M-8.7% | $1.04B-2.2% | $1.07B-0.7% | $1.07B+3.7% | ||
| $196.2M0.0% | $196.2M0.0% | $196.2M0.0% | $196.2M0.0% | ||
| $213.84M-16.2% | $255.28M-13.4% | $294.7M-13.0% | $338.57M-12.9% | ||
| $7.59B+8.7% | $6.99B+2.2% | $6.84B+7.3% | $6.38B+6.2% | ||
| $759.03M+25.0% | $606.99M-11.1% | $683.15M+19.2% | $572.96M+15.0% | ||
| $759.03M+25.0% | $606.99M-48.4% | $1.18B+99.9% | $588.88M+7.8% | ||
| $597.18M— | —— | —— | —— | ||
| $1.51B+13.2% | $1.33B-29.6% | $1.89B+6.7% | $1.77B+1.9% | ||
| 500M+261,680% | 191K+1.1% | 189K+1.6% | 186K+1.1% | ||
| $154.21M+179% | -$194.7M+68.7% | -$621.55M+21.2% | -$789.2M+15.2% | ||
| $6.09B+7.6% | $5.66B+14.3% | $4.95B+7.6% | $4.6B+7.9% | ||
| $7.59B+8.7% | $6.99B+2.2% | $6.84B+7.3% | $6.38B+6.2% |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- What are BioMarin Pharmaceuticals's total assets?
- BioMarin Pharmaceuticals (BMRN) holds $8.6B in total assets, up 20.2% year over year.
- How much debt does BioMarin Pharmaceuticals have?
- BioMarin Pharmaceuticals carries $1.4B in total debt against $6.2B of shareholders' equity, a debt-to-equity ratio of 0.23.
- How much cash does BioMarin Pharmaceuticals have?
- BioMarin Pharmaceuticals holds $3.1B in cash and equivalents.
- Can BioMarin Pharmaceuticals cover its short-term obligations?
- Its current ratio is 5.81 — current assets exceed current liabilities.
- Where does BioMarin Pharmaceuticals's balance sheet data come from?
- Every line is extracted from BioMarin Pharmaceuticals's SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.
